Finland· FI-REL-REL58075
Primovist
A gadoxetsäure product containing gadoxetate disodium, registered in Finland by Orifarm Oy. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Gadoxetsäure is registered in 12 of 19 countries.
Countries holding a registration under ATC V08CA10 (gadoxetsäure), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Gadoxetsäure · ATC V08CA10
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Gadoxetate disodium
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- V08CA10
- ATC class
- Gadoxetsäure
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa3911195 x 10 mlEUR 936.78
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
34 interactions on record for gadoxetsäure.
Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gadoxetsäure · interactions on record
34 records
- 34 moderate
Most severe, free to view
- PindololC07AA03moderate
- PropranololC07AA05moderate
- TimololC07AA06moderate
- SotalolC07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gadoxetsäure in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8f8a8145-117e-4cb0-9979-d8ea5c9eaed3 GET /v1/drugs/8f8a8145-117e-4cb0-9979-d8ea5c9eaed3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos, esitäytetty ruisku",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "0.25 mmol/ml",
"atc_label": "gadoksetiinihappo",
"ma_number": "39014",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL58075",
"authorised_at": "2021-11-16"
}See everything about gadoxetsäure.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.